| LDR | 01173nam a22002531 4500 | ||
| 001 | 002075227 | ||
| 003 | MiAaHDL | ||
| 005 | 20220528000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 900730s1961 dcu||||||||||f||||||eng|d | ||
| 035 | ⊔ | ⊔ | ‡a(MiU)990020752270106381 |
| 035 | ⊔ | ⊔ | ‡asdr-miu.990020752270106381 |
| 035 | ⊔ | ⊔ | ‡z(MiU)MIU01000000000000002075227-goog |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)8386111 |
| 035 | ⊔ | ⊔ | ‡a(SAZTEC)126403440 |
| 035 | ⊔ | ⊔ | ‡a(CaOTULAS)175827103 |
| 035 | ⊔ | ⊔ | ‡z(MiU)Aleph002075227 |
| 040 | ⊔ | ⊔ | ‡cSAZTEC |
| 245 | 0 | 0 | ‡aIndividual statements by physicians, research scientists, and medical educators on S.1552 ‡b[the drug industry antitrust act] December 7, 1961. |
| 260 | ⊔ | ⊔ | ‡a[Washington, ‡c1961?] |
| 300 | ⊔ | ⊔ | ‡a1 v. (various pagings) |
| 500 | ⊔ | ⊔ | ‡aMost of the statements were made to the Senate Subcommittee on Antitrust and Monopoly, Committee on the Judiciary, in connection with the hearings of Dec. 6-8, 1961 and were made on behalf of the Pharmaceutical Manufacturers Association. |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 610 | 2 | 0 | ‡aPharmaceutical Manufacturers Association. |
| 650 | ⊔ | 0 | ‡aDrugs ‡xLaw and legislation ‡zUnited States |
| 710 | 1 | ⊔ | ‡aUnited States. ‡bCongress. ‡bSenate. ‡bCommittee on the Judiciary. |
| 899 | ⊔ | ⊔ | ‡a39015072274841 |
| CID | ⊔ | ⊔ | ‡a002075227 |
| DAT | 0 | ⊔ | ‡a19900730000000.0 ‡b20220528000000.0 |
| DAT | 1 | ⊔ | ‡a20220529134955.0 ‡b2023-08-08T17:58:25Z |
| CAT | ⊔ | ⊔ | ‡aSDR-MIU ‡dALMA ‡lprepare.pl-004-008 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-miu.990020752270106381 ‡aMiU ‡bSDR ‡cMIU ‡pmdp.39015072274841 ‡sMIU ‡1990020752270106381 |
| 974 | ⊔ | ⊔ | ‡bMIU ‡cMIU ‡d20230808 ‡sgoogle ‡umdp.39015072274841 ‡y1961 ‡rpd ‡qbib ‡tUS fed doc |